| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $100K | +0.0% |
| R&D Expense | $2.8M | +74.4% |
| SG&A Expense | $24.9M | +732.3% |
| Operating Income | -$27.7M | -1950.7% |
| Net Income | -$35.8M | -311.2% |
| EPS (Basic) | -$107.01 | -7179.6% |
| EPS (Diluted) | -$107.01 | -7179.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | — |
| Current Assets | $3.8M | +6084.5% |
| Total Assets | $3.8M | -55.0% |
| Current Liabilities | $22.3M | +80.7% |
| Total Liabilities | $30.4M | +133.9% |
| Stockholders' Equity | -$26.7M | -105.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.2M | -1152.9% |
| Capital Expenditures | $8K | — |
| Investing Cash Flow | -$2.0M | -167.7% |
| Financing Cash Flow | $19.8M | +1295.7% |
| Free Cash Flow | -$16.3M | — |